Biotechnology Daily
more-
Kezar drops solid tumor drug that has yet to prove worth in phase 1
Kezar Life Sciences is dropping its unpromising phase 1 solid tumor drug as the biotech…
Biotech leader jumps to oncology CRO Pi Health
Acelyrin loses interest in izokibep, lays off 3rd of staff to focus on looming fight for Tepezza’s crown
Ovid halts preclinical work, IV seizure program in wake of soticlestat’s phase 3 stumble
Rivus succeeds in obesity-related heart failure, posting phase 2 win for muscle-sparing molecule
Market Watch
more-
Walmart Heads Into Official Start of Holiday Season With Strong Momentum After Robust 3Q Results
Walmart ratcheted up sales and profits again in the third quarter with its comparatively low…
Bio Business News
more
Evotec eyes 400 layoffs, citing ‘challenging market’
Evotec has set its sights on scrapping around 400 roles…
White House announces $150M in ARPA-H awards for precision cancer surgery
As part of its national cancer moonshot efforts, the Biden…
To pay down debt, Baxter sells its $4.5B Vantive kidney care division to the Carlyle Group for $3.8B
The Carlyle Group is finally closing in on its major…
World News
more
Stocks close with a round of records, Dow clinches 35,000
U.S. stocks swept to another round of records Monday as…
Equifax stock surges toward biggest gain in 12 years after ‘impressive’ business update
Shares of Equifax Inc. EFX, +7.84% shot up 9.3% into…
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Kezar drops solid tumor drug that has yet to prove worth in phase 1
Biotech leader jumps to oncology CRO Pi Health
Acelyrin loses interest in izokibep, lays off 3rd of staff to focus on looming fight for Tepezza’s crown
Ovid halts preclinical work, IV seizure program in wake of soticlestat’s phase 3 stumble
Evotec eyes 400 layoffs, citing ‘challenging market’
White House announces $150M in ARPA-H awards for precision cancer surgery
To pay down debt, Baxter sells its $4.5B Vantive kidney care division to the Carlyle Group for $3.8B
Eli Lilly unwraps $700M nucleic acid R&D center in Boston Seaport, opens doors to biotechs
Walmart Heads Into Official Start of Holiday Season With Strong Momentum After Robust 3Q Results
Nvidia Helps Pull US Indexes Higher